These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 23994420

  • 1. Allopurinol reduces left ventricular mass in patients with type 2 diabetes and left ventricular hypertrophy.
    Szwejkowski BR, Gandy SJ, Rekhraj S, Houston JG, Lang CC, Morris AD, George J, Struthers AD.
    J Am Coll Cardiol; 2013 Dec 17; 62(24):2284-93. PubMed ID: 23994420
    [Abstract] [Full Text] [Related]

  • 2. High-dose allopurinol reduces left ventricular mass in patients with ischemic heart disease.
    Rekhraj S, Gandy SJ, Szwejkowski BR, Nadir MA, Noman A, Houston JG, Lang CC, George J, Struthers AD.
    J Am Coll Cardiol; 2013 Mar 05; 61(9):926-32. PubMed ID: 23449426
    [Abstract] [Full Text] [Related]

  • 3. Insertion/deletion polymorphism of angiotensin I converting enzyme gene and left ventricular hypertrophy in patients with type 2 diabetes mellitus.
    Moleda P, Majkowska L, Kaliszczak R, Safranow K, Adler G, Goracy I.
    Kardiol Pol; 2006 Sep 05; 64(9):959-65; discussion 966. PubMed ID: 17054027
    [Abstract] [Full Text] [Related]

  • 4. Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy: the Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study.
    Okin PM, Devereux RB, Gerdts E, Snapinn SM, Harris KE, Jern S, Kjeldsen SE, Julius S, Edelman JM, Lindholm LH, Dahlöf B, LIFE Study Investigators.
    Circulation; 2006 Mar 28; 113(12):1588-96. PubMed ID: 16534012
    [Abstract] [Full Text] [Related]

  • 5. Discrepancies in Left Ventricular Mass Calculation Based on Echocardiography and Cardiovascular Magnetic Resonance Measurements in Patients with Left Ventricular Hypertrophy.
    Seo HY, Lee SP, Park JB, Lee JM, Park EA, Chang SA, Kim HK, Park SJ, Lee W, Kim YJ, Lee SC, Park SW, Sohn DW, Choe YH.
    J Am Soc Echocardiogr; 2015 Oct 28; 28(10):1194-1203, e2. PubMed ID: 26194306
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Improving cardiovascular risk stratification in essential hypertensive patients by indexing left ventricular mass to height(2.7).
    Cuspidi C, Giudici V, Negri F, Meani S, Sala C, Zanchetti A, Mancia G.
    J Hypertens; 2009 Dec 28; 27(12):2465-71. PubMed ID: 19898252
    [Abstract] [Full Text] [Related]

  • 8. A study of the relationships between angiotensin- converting enzyme gene, chymase gene polymorphisms, pharmacological treatment with ACE inhibitor and regression of left ventricular hypertrophy in essential hypertension patients treated with benazepril.
    He H, Li LM, Cao WH, Sun NL, Liu MZ, Hu YH.
    Ann Hum Biol; 2005 Dec 28; 32(1):30-43. PubMed ID: 15788353
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Reduction (TELMAR) as assessed by magnetic resonance imaging in patients with mild-to-moderate hypertension--a prospective, randomised, double-blind comparison of telmisartan with metoprolol over a period of six months rationale and study design.
    Friedrich MG, Dahlöf B, Sechtem U, Unger T, Knecht M, Dietz R, TELMAR Investigators.
    J Renin Angiotensin Aldosterone Syst; 2003 Dec 28; 4(4):234-43. PubMed ID: 14689371
    [Abstract] [Full Text] [Related]

  • 11. Cardiac magnetic resonance assessment of left ventricular mass in autosomal dominant polycystic kidney disease.
    Perrone RD, Abebe KZ, Schrier RW, Chapman AB, Torres VE, Bost J, Kaya D, Miskulin DC, Steinman TI, Braun W, Winklhofer FT, Hogan MC, Rahbari-Oskoui F, Kelleher C, Masoumi A, Glockner J, Halin NJ, Martin D, Remer E, Patel N, Pedrosa I, Wetzel LH, Thompson PA, Miller JP, Bae KT, HALT PKD Study Group, Meyers CM.
    Clin J Am Soc Nephrol; 2011 Oct 28; 6(10):2508-15. PubMed ID: 21903983
    [Abstract] [Full Text] [Related]

  • 12. Left ventricular mass and hypertrophy assessment by means of the QRS complex voltage-independent measurements.
    Sosnowski M, Korzeniowska B, Tendera M.
    Int J Cardiol; 2006 Jan 26; 106(3):382-9. PubMed ID: 15996771
    [Abstract] [Full Text] [Related]

  • 13. Left ventricular hypertrophy: reduction of blood pressure already in the normal range further regresses left ventricular mass.
    Simpson HJ, Gandy SJ, Houston JG, Rajendra NS, Davies JI, Struthers AD.
    Heart; 2010 Jan 26; 96(2):148-52. PubMed ID: 19858141
    [Abstract] [Full Text] [Related]

  • 14. Hypertensive left ventricular hypertrophy: a mechanistic approach to optimizing regression assessed by cardiovascular magnetic resonance.
    Burns J, Ball SG, Worthy G, Struthers AD, Mary DA, Greenwood JP.
    J Hypertens; 2012 Oct 26; 30(10):2039-46. PubMed ID: 22828088
    [Abstract] [Full Text] [Related]

  • 15. Rationale and design of a multicentre, randomized, placebo-controlled trial of mirabegron, a Beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3-left ventricular hypertrophy (Beta3-LVH).
    Pouleur AC, Anker S, Brito D, Brosteanu O, Hasenclever D, Casadei B, Edelmann F, Filippatos G, Gruson D, Ikonomidis I, Lhommel R, Mahmod M, Neubauer S, Persu A, Gerber BL, Piechnik S, Pieske B, Pieske-Kraigher E, Pinto F, Ponikowski P, Senni M, Trochu JN, Van Overstraeten N, Wachter R, Balligand JL.
    ESC Heart Fail; 2018 Oct 26; 5(5):830-841. PubMed ID: 29932311
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Relation between abdominal obesity, insulin resistance and left ventricular hypertrophy diagnosed by electrocardiogram and magnetic resonance imaging in hypertensive patients.
    Vernooij JW, Cramer MJ, Visseren FL, Korndewal MJ, Bots ML, Meijs MF, Doevendans PA, Spiering W, Smart Study Group.
    Am J Cardiol; 2012 Jul 15; 110(2):227-33. PubMed ID: 22483385
    [Abstract] [Full Text] [Related]

  • 18. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
    Okin PM.
    J Electrocardiol; 2009 Jul 15; 42(6):584-8. PubMed ID: 19631946
    [Abstract] [Full Text] [Related]

  • 19. Incidence of left ventricular hypertrophy in children with kidney disease: impact of method of indexation of left ventricular mass.
    Simpson JM, Savis A, Rawlins D, Qureshi S, Sinha MD.
    Eur J Echocardiogr; 2010 Apr 15; 11(3):271-7. PubMed ID: 20015849
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.